Yoshiharu Yamanobe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yoshiharu Yamanobe has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Atsuko Nakano
Division of Otorhinolaryngology, Chiba Children's Hospital, 579-1 Heta-cho, Chiba-shi, Chiba, 266-0007, Japan
1 shared publication - Hirokazu Sakamoto
Department of Otolaryngology, Graduate School of Medicine Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka-shi 545-8585, Osaka, Japan
1 shared publication - Kimitaka Kaga
National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Audiology Clinic, Kamio Memorial Hospital
1 shared publication - Noriko Morita
Department of Otorhinolaryngology, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8606, Japan
1 shared publication - Sawako Masuda
Department of Otorhinolaryngology, National Hospital Organization Mie National Hospital, 357 Osato-Kubota, Tsu 514-0125, Mie, Japan
1 shared publication - Sayaka Katsunuma
Department of Otolaryngology, Hyogo Prefectural Kobe Children’s Hospital, 1-6-7 Minatojima Minami-cho, Chuo-ku, Kobe-shi 650-0047, Hyogo, Japan
1 shared publication
Latest Publications
- Open Access
- 29 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5056
A High Risk of Missing Congenital Cytomegalovirus-Associated Hearing Loss through Newborn Hearing Screening in Japan
It remains unclear to what extent newborn hearing screening (NHS) detects congenital cytomegalovirus (cCMV)-associated sensorineural hearing loss (SNHL) in Japan. This study aimed to clarify the NHS results and audiological characteristics of patients with cCMV-associated SNHL. A total of 541 individuals with unilateral or bilateral hearing loss of unknown etiology were examined for cCMV infection. cCMV infection was defined by the presence of CMV DNA in the dried umbilical cord detected using real-time quantitative PCR. NHS results and audiological data were retrospectively obtained from medical records. Forty-four cases (8.1%) were positive for cCMV infection. Of them, 33 cases underwent NHS and 13 cases (39.4%) passed NHS bilaterally. The pure-tone audiograms of 21 patients were obtained. There were seven cases of unilateral SNHL, five cases of asymmetric bilateral SNHL, and nine cases of symmetric bilateral SNHL. cCMV-related hearing loss is highly heterogeneous, and there is a high risk of missing this condition through NHS.
- 29 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5056
Open AccessA High Risk of Missing Congenital Cytomegalovirus-Associated Hearing Loss through Newborn Hearing Screening in Japan
It remains unclear to what extent newborn hearing screening (NHS) detects congenital cytomegalovirus (cCMV)-associated sensorineural hearing loss (SNHL) in Japan. This study aimed to clarify the NHS results and audiological characteristics of patients with cCMV-associated SNHL. A total of 541 individuals with unilateral or bilateral hearing loss of unknown etiology were examined for cCMV infection. cCMV infection was defined by the presence of CMV DNA in the dried umbilical cord detected using real-time quantitative PCR. NHS results and audiological data were retrospectively obtained from medical records. Forty-four cases (8.1%) were positive for cCMV infection. Of them, 33 cases underwent NHS and 13 cases (39.4%) passed NHS bilaterally. The pure-tone audiograms of 21 patients were obtained. There were seven cases of unilateral SNHL, five cases of asymmetric bilateral SNHL, and nine cases of symmetric bilateral SNHL. cCMV-related hearing loss is highly heterogeneous, and there is a high risk of missing this condition through NHS.